We are sure you appreciate that there is a lack of clear guidance if a long acting reversible contraception (LARC) has to be discontinued prior to ovarian stimulation for women donating their eggs or having fertility preservation, and anecdotally, we have come across some variation in clinical practice.

We would be grateful if you could answer these questions in this short survey to enable a better picture to be built of policy practices so that future guidance on this question can be developed.

Mariano Mascarenhas, Harish Bhandari and Melanie Davies